Monopar Therapeutics
MNPR
Revenue
0.00
0.000.00%
3 Months ChangeAssets
7.18M
▼-1.73M▼-19.44%
3 Months ChangeLiabilities
1.09M
▼-345.70k▼-24.09%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001437749-24-032612
2024-10-24
Form 8-K
ID: 0001437749-24-031957
2024-10-22
Form 8-K
ID: 0001437749-24-031684
2024-10-15
Form 8-K
ID: 0001437749-24-031184
2024-10-07
Form 8-K
ID: 0001437749-24-030764
2024-09-12
Form 8-K
ID: 0001437749-24-029012
2024-08-27
Form 8-K
ID: 0001437749-24-027846
2024-08-21
Form 8-K
ID: 0001437749-24-027432
2024-08-14
Form 8-K
ID: 0001437749-24-026563
2024-08-09
Form 10-Q
ID: 0001437749-24-025651